Oct 2, 2026 · 28 min
Gas stations become battlegrounds over opioid-like products
Gas station opioids
The episode examines whether concentrated 7-OH should be banned while kratom remains available as regulators weigh dependence, uncertain risks, and possible harm reduction.
- 1Kratom has moved from traditional Southeast Asian use into a fast-growing American market of capsules, gummies, shots, and drinks.
- 2Concentrated 7-OH products deliver a sharper regulatory challenge because dependence and withdrawal concerns accompany aggressive, childlike packaging and easy access.
- 3The emerging policy divide separates 7-OH from kratom, reflecting tensions between drug enforcement, personal freedom, commercial interests, and harm reduction.
Don't miss
The discussion predicts that 7-OH may be pushed underground while kratom continues expanding in American culture.
The brief
A Northern Virginia gas station introduces the central contradiction: opioid-like products are sold as capsules, gummies, shots, and drinks in ordinary convenience stores.
Journalist Mattha Busby explains how kratom evolved from traditional Southeast Asian use into an American industry, while concentrated 7-OH is marketed as a more potent product.
The episode separates broad kratom use from 7-OH, examining dependence, withdrawal, uncertain overdose evidence, and lawsuits involving Feel Free kava-and-kratom tonics.
The political fight brings Robert F. Kennedy Jr. and other officials into an unusual debate over industry lobbying, personal freedom, and childlike packaging.
The likely compromise would push 7-OH underground while leaving kratom legal, preserving both a possible harm-reduction tool and a growing source of risk.
Featuring
Kratom
Robert F. Kennedy Jr.
United StatesListen to the full episode and explore every guest, topic, and moment on PodLume.